Results 181 to 190 of about 7,464 (222)

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Paul E Sax, David Alain Wohl, Michael T Yin   +2 more
exaly  

ELVITEGRAVIR / COBICISTAT /

2015
openaire   +1 more source

Cobicistat/darunavir/emtricitabine/tenofovir

Reactions Weekly, 2020
openaire   +1 more source

Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers

Circulation, 2016
Lori A Gordon, Kristina M Brooks
exaly  

Cobicistat/triamcinolone interaction

Reactions Weekly, 2018
openaire   +1 more source

Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection

Clinical Therapeutics, 2015
Elizabeth M Sherman, Nathan R Unger, Jason J Schafer   +2 more
exaly  

Cobicistat/darunavir/dolutegravir

Reactions Weekly, 2018
openaire   +1 more source

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

ACS Medicinal Chemistry Letters, 2010
Allen Hong
exaly  

Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection

Pharmacotherapy, 2013
Jason J Schafer
exaly  

Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV

Expert Opinion on Drug Metabolism and Toxicology, 2019
Dario Cattaneo, Giuliano Rizzardini
exaly